Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Clinical Oncology|June 15, 2020
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study)Naohiro Okano, Chigusa Morizane, Shogo Nomura, et al.
The Oncologist|July 16, 2020
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)Hironaga Satake, Takeshi Kato, Koji Oba, et al.
The Oncologist|September 13, 2017
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational StudyToshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi, et al.
The New England Journal of Medicine|December 22, 2022
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic CancerJohn H Strickler, Hironaga Satake, Thomas J George, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2026
Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)Yosuke Kito, Kentaro Yamazaki, Hirokazu Shoji, et al.
Clinical Colorectal Cancer|August 29, 2018
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal CancerKenji Tsuchihashi, Mamoru Ito, Toshikazu Moriwaki, et al.
Nature Medicine|September 16, 2024
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumorsYoshiaki Nakamura, Hiroshi Ozaki, Makoto Ueno, et al.
Cancer Research Communications|May 9, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN StudyKentaro Sawada, Riu Yamashita, Shunsuke A Sakai, et al.
JAMA Oncology|September 4, 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialKohei Shitara, Eric Van Cutsem, Yung-Jue Bang, et al.
Journal of Gastroenterology|March 23, 2026
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)Kohei Okamoto, Susumu Hijioka, Noritoshi Kobayashi, et al.
Pageof 12